Actively Recruiting

Age: 40Years +
All Genders
NCT07579052

CLEAR Model for Predicting Ventilatory Liberation in Severe COPD

Led by Assiut University · Updated on 2026-05-11

400

Participants Needed

1

Research Sites

65 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This prospective observational cohort study aims to prospectively evaluate and validate the Clinical Load, Exchange, Ability of Respiration, and Reserve (CLEAR) model for predicting sustained ventilatory liberation in patients with severe chronic obstructive pulmonary disease (COPD) receiving invasive mechanical ventilation (MV) or non-invasive ventilation (NIV). Two parallel cohorts will be studied: CLEAR-MV for patients undergoing spontaneous breathing trials (SBT) and CLEAR-NIV for patients undergoing NIV withdrawal trials. The model integrates diaphragm ultrasound evaluating diaphragm thickening fraction (DTF), ventilatory load indices including the rapid shallow breathing index (RSBI) or Clinical Load Index (CLI), gas exchange parameters including Potential of Hydrogen (pH), partial pressure of carbon dioxide (PaCO₂), and its change over time (ΔPaCO₂) combined as the Gas Exchange Index (GEI), and peripheral muscle reserve assessing rectus femoris (RF) and vastus intermedius (VI) thickness. The primary outcome is successful liberation from ventilatory support within 72 hours. Secondary outcomes include ventilatory failure within 7 days, ventilator- or NIV-free days at 28 days, and time-fixed 90-day clinical outcomes including all-cause mortality, sustained ventilatory independence, and rehospitalization for respiratory failure. Model performance will be evaluated using discrimination (area under the receiver operating characteristic curve), calibration (calibration intercept and slope), and clinical utility (decision curve analysis and net benefit) and compared with prespecified established ventilatory indices, including the Rapid Shallow Breathing Index (RSBI) and Integrative Weaning Index (IWI) in the invasive mechanical ventilation cohort, and the Heart rate, Acidosis, Consciousness, Oxygenation, and Respiratory rate (HACOR) score and the ratio of peripheral oxygen saturation to fraction of inspired oxygen divided by respiratory rate (ROX) index in the non-invasive ventilation cohort.

CONDITIONS

Official Title

CLEAR Model for Predicting Ventilatory Liberation in Severe COPD

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 40 years or older
  • Confirmed or clinically diagnosed chronic obstructive pulmonary disease (COPD) based on prior spirometry or consistent clinical history
  • Admission to the intensive care unit (ICU) with acute respiratory failure requiring ventilatory support
  • Receiving invasive mechanical ventilation (MV) or non-invasive ventilation (NIV)
  • Considered clinically ready for ventilatory withdrawal: Undergoing spontaneous breathing trial (SBT) in the MV cohort or undergoing structured withdrawal or low-support trial in the NIV cohort
Not Eligible

You will not qualify if you...

  • Age younger than 40 years
  • Primary diagnosis other than COPD causing respiratory failure (e.g., isolated pneumonia, cardiogenic pulmonary edema without COPD exacerbation)
  • Known neuromuscular disease affecting respiratory muscle function
  • Significant chest wall deformity or restrictive thoracic disorder affecting ventilatory mechanics
  • Presence of tracheostomy at baseline
  • Hemodynamic instability requiring high-dose vasopressors at the time of assessment
  • Inability to perform diaphragm or muscle ultrasound (e.g., poor acoustic window, extensive dressings)
  • Reduced level of consciousness precluding valid clinical assessment (outside expected NIV cohort context)
  • Refusal of consent by patient or legal representative

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Assuit Univeristy

Asyut, Assuit Egypt, Egypt, 71515

Actively Recruiting

Loading map...

Research Team

A

Ahmad M. Shaddad, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here